The White House has withdrawn the nomination of Dr Heidi Overton to lead the Food and Drug Administration, abandoning a confirmation fight that senators from both parties had made increasingly untenable, CNN and The Guardian reported.
Overton, a senior White House aide and physician nominated in August, faced opposition from Republican senators including Susan Collins and Lisa Murkowski, and what CNN described as an “icy” relationship with Robert F. Kennedy Jr.’s Make America Healthy Again movement — “She’s not MAHA” was the charge from that wing. The Guardian reported bipartisan questions about her willingness to break from President Trump, and that she had supported his plan to break up combination vaccines.
The arithmetic that killed it
Overton would have needed all 12 Republicans on the Senate health committee, which Senator Bill Cassidy chairs. Cassidy’s verdict on the withdrawal was blunt: “Tonight, the White House abandoned a viable confirmation path.” The Guardian reported Republicans had been racing to confirm nominees before handing over power — which makes abandoning one at this stage a notable concession.
Overton is a prominent abortion opponent; a 2023 policy brief she wrote for the America First Policy Institute said Congress should strictly regulate medication abortions. Reproductive Freedom for All, an abortion-rights group, celebrated the withdrawal.
What it means
The FDA is now likely to go without a permanent, confirmed leader well into next year — an agency that regulates a fifth of the US economy, run on an acting basis, at the start of a new Congress. Who the White House names instead, and whether the choice is designed to satisfy the MAHA wing or the Senate’s sceptics, will say a great deal about which constituency the administration fears more.




0 comments